Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 122,536 | 94,603 | 35,572 | 89,833 | 50,606 |
| Depreciation Amortization | 2,048 | 1,355 | 607 | 3,259 | 2,204 |
| Accounts receivable | -18,885 | -30,677 | -25,626 | -141,992 | -89,646 |
| Accounts payable and accrued liabilities | -13,108 | -5,132 | -4,959 | 9,893 | -1,436 |
| Other Working Capital | -42,161 | -48,119 | -33,520 | -112,534 | -70,477 |
| Other Operating Activity | 70,591 | 61,638 | 41,403 | 179,896 | 119,394 |
| Operating Cash Flow | $121,021 | $73,668 | $13,477 | $28,355 | $10,645 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,279 | -4,167 | -1,783 | -1,822 | -1,435 |
| Net Acquisitions | 167 | 167 | 167 | N/A | N/A |
| Purchase Of Investment | -273,845 | -231,864 | N/A | -20,235 | -20,235 |
| Sale Of Investment | 63,000 | 0 | N/A | 20,400 | 15,000 |
| Other Investing Activity | -7,500 | -5,000 | 0 | -11,075 | 0 |
| Investing Cash Flow | $-224,457 | $-240,864 | $-1,616 | $-12,732 | $-6,670 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -18,170 | -18,170 | N/A | N/A | N/A |
| Common Stock Issued | 13,014 | 8,105 | 4,803 | 13,711 | 13,337 |
| Common Stock Repurchased | 2,557 | 2,557 | N/A | 3,519 | 1,878 |
| Other Financing Activity | 221,032 | 221,853 | -880 | 72,140 | 72,955 |
| Financing Cash Flow | $218,433 | $214,345 | $3,923 | $89,370 | $88,170 |
| Exchange Rate Effect | N/A | N/A | N/A | -276 | -170 |
| Beginning Cash Position | 177,908 | 177,908 | 177,908 | 73,191 | 73,191 |
| End Cash Position | 292,905 | 225,057 | 193,692 | 177,908 | 165,166 |
| Net Cash Flow | $114,997 | $47,149 | $15,784 | $104,717 | $91,975 |
| Free Cash Flow | |||||
| Operating Cash Flow | 121,021 | 73,668 | 13,477 | 28,355 | 10,645 |
| Capital Expenditure | -6,279 | -4,167 | -1,783 | -1,822 | -1,435 |
| Free Cash Flow | 114,742 | 69,501 | 11,694 | 26,533 | 9,210 |